1. Home
  2. MAX vs VALN Comparison

MAX vs VALN Comparison

Compare MAX & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MediaAlpha Inc.

MAX

MediaAlpha Inc.

HOLD

Current Price

$10.76

Market Cap

465.5M

Sector

Industrials

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$5.23

Market Cap

536.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAX
VALN
Founded
2014
2012
Country
United States
France
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
465.5M
536.9M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
MAX
VALN
Price
$10.76
$5.23
Analyst Decision
Buy
Strong Buy
Analyst Count
5
2
Target Price
$12.70
$15.50
AVG Volume (30 Days)
552.1K
23.7K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
25.81
N/A
EPS
0.21
N/A
Revenue
$1,113,600,000.00
N/A
Revenue This Year
$13.42
N/A
Revenue Next Year
$8.16
$93.87
P/E Ratio
$49.29
N/A
Revenue Growth
28.78
N/A
52 Week Low
$7.09
$5.06
52 Week High
$13.92
$12.25

Technical Indicators

Market Signals
Indicator
MAX
VALN
Relative Strength Index (RSI) 70.54 37.71
Support Level $10.54 $5.11
Resistance Level $13.83 $6.69
Average True Range (ATR) 0.54 0.18
MACD 0.15 0.00
Stochastic Oscillator 94.11 17.17

Price Performance

Historical Comparison
MAX
VALN

About MAX MediaAlpha Inc.

MediaAlpha Inc provides a platform that enables insurance carriers and distributors to target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It serves as a customer acquisition channel in property and casualty insurance, health insurance, and life insurance. The company operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: